Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04008719
Other study ID # D17-P02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 16, 2017
Est. completion date September 30, 2019

Study information

Verified date July 2019
Source Centre Hospitalier St Anne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether cognitive function evaluation (sustained attention, executive functions, working memory) during acute post-stroke is predictive of a 3 months post-stroke depression.


Description:

1. Baseline visit: after neurologic stability, 14 days or less after stroke and before discharge. 2. First assessment : 1. Neurologic data: morphologic data (MRI of the brain), stroke severity (NIHSScore), aphasia assessment (Boston Diagnostic Aphasia Examination) if NIHS verbal score ≥1, hemineglect assessment (Bells test). 2. Personal data assessment : i. Socio demographic : age, gender, marital status, employment, level of education ii. Medical history: medical treatments, psychiatric and non psychiatric history. c. Psychiatric assessment i. Mini International Neuropsychiatric Interview - depression ii. Beck Depression Inventory iii. Clinical Global Impression iv. Standardized Assessment of Personality - Abbreviated Scale (SAPAS) v. Fageström-C vi. Alcohol Use Disorders Identification Test (AUDIT-C) d. Cognitive assessment: i. Verbal memory : Dubois's five words ii. Clock drawing test iii. D2test (computerized) iv. Verbal fluency (Cardebat) v. Working memory (digit span WAIS 3) vi. Brixton (computerized) 3. Assessment 3 months after the first assessment. Phone call and psychiatric assessment: MINI depression, Beck Depression Inventory. Barthel index and Quality of Life assessment.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date September 30, 2019
Est. primary completion date September 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or more - Ischemic or hemorragic stroke, diagnosed with radiology : cerebral CT or MRI, 14 days or less after stroke - Signed Consent - Social insurance regime affiliation Exclusion Criteria: - Death - No possibility of follow-up - No French-speaker : insufficient command of French - Deprivation of liberty : judicial or administrative decision - D2 test assessment impossibility - Aphasia with major disorder of the understanding (Boston <8) - Antidepressant treatment during stroke - Depression during stroke - protected people

Study Design


Intervention

Other:
Thymic history
This interview concerns mainly the nature of the previous psychiatric and psychological care
Evaluation of the psychiatric disorders
Mini International Neuropsychiatric Interview for the positive diagnosis of depression - under the MINI score of depression.
Cognitive evaluation
They will be held consecutively to the patient's bedside interview on the same day. Some tests will be computerized, others will be in paper form.

Locations

Country Name City State
France Neurology service Paris

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier St Anne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post stroke depression Whether or not a post-stroke depression occurs. occurrence of post-stroke depression assessed with Mini International Neuropsychiatric Interview (MINI), subscale depression . 3 months
Secondary Post-stroke depression population characterization Age, gender, marital status, occupation, level of education, laterality of stroke,and medical and psychiatric history will be collected during the inclusion interview and cognitive tests 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05612659 - Developing an EEG Probe for Studying and Modulating Cognitive Control N/A
Active, not recruiting NCT06451965 - SCED - Wisdom Enhancement for Post-Stroke Depression N/A
Completed NCT04093843 - TMS for Post Stroke Depression N/A
Recruiting NCT05516680 - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD N/A
Recruiting NCT04876066 - Use of Transmucosal Ketamine in Post Stroke Depression Phase 1
Recruiting NCT03159351 - The Antidepressant Effects of rTMS After Ischemic Stroke N/A
Recruiting NCT03864484 - iPad Application-based Intervention for Post-stroke Depression N/A
Recruiting NCT05310175 - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression N/A
Completed NCT03639259 - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed NCT02472613 - Acupuncture for Ischemic Post-stroke Depression N/A
Recruiting NCT05241782 - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients N/A
Withdrawn NCT03761303 - rTMS as an add-on Therapy in Patients With Post-stroke Depression N/A
Completed NCT04318951 - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia N/A
Completed NCT04560413 - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Recruiting NCT05187975 - Integrated Rehabilitation in Treating Post-stroke Depression N/A
Completed NCT06157333 - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression N/A
Completed NCT03829397 - To Investigate the Correlation of Stroke Patients and Demoralized
Recruiting NCT03256305 - A Study of rTMS Personalized Precision Treatment of Post-stroke Depression N/A
Recruiting NCT03789994 - Affective Touching on Poststroke Depression N/A
Completed NCT05932550 - Safety of Maraviroc for Post-stroke Depression Phase 2